True Beasley, but they also have a product that had gone thru phase I and II and working on III. Have product stockpiled, have saved lives in hospitals right now, etc. but they also have 7 times more shares outstanding so that makes us look worse. If they only had 80M shares out, then their price would be about $28.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.